Pediatric salivary gland neoplasms are the fourth most common pediatric head and neck tumor. They account for 8% of all pediatric head and neck tumors and present as malignant lesions 50% of the time when vascular lesions are excluded. There are no standardized protocols for the management of salivary gland malignancies in the pediatric population due to a wide variety of presentations and pathologies. Surgical management itself presents various challenges due to the size of the patients and, depending on age, location of the facial nerve. The utilization of post-surgical treatment still remains controversial as well. This panel will involve experts who have multi-disciplinary practices focused on the management of pediatric patients with salivary gland tumors. This discussion will focus on the presentation and management differences and similarities in this population relative to adult tumors. Additionally, this panel will discuss the treatment challenges in this population related to anatomy and varying pathologies.